This study investigates the drug release performance of electrospun composite nanofiber mats, which hold significant promise as drug carriers for site-specific delivery in therapeutic applications such as cancer therapy. Predicting drug release rates from poly(D,L-lactic-co-glycolic acid) (PLGA) nanofibers produced via emulsion electrospinning is challenging due to the system's inherent complexity. To address this, two distinct implants were fabricated at the Faculty of Technology and Metallurgy, University of Belgrade: a PLGA implant and a composite scaffold consisting of a PLGA fibrous structure enclosed between two layers of poly(ε-caprolactone) (PCL), prepared via emulsion-based and sequential electrospinning techniques. Computational modeling was employed to evaluate the continuous drug release from these nanofibers. The study utilized the PAK software program and a CAD user interface to create nano-implant models, with post-processing by the PAK finite element (FE) solution. Two models were developed to simulate diffusive drug release from nanofibers into a three-dimensional (3D) surrounding medium: (1) a one-dimensional (1D) finite elements with axial and radial diffusion representing the fibers, and (2) a 3D continuum discretized using composite smeared finite elements (CSFEs); with coupling of these models two models. Both models account for polymer degradation and drug hydrophobicity as partitioning at the fiber/surrounding interface. Experimental drug release rates from the scaffold were compared with computational predictions from the FE models. The results demonstrate the effectiveness of the proposed models in capturing the complex dynamics of drug release, providing valuable insights into the design and optimization of electrospun nanofiber-based drug delivery systems. This work highlights the potential of integrating experimental and computational approaches to advance the development of controlled drug release platforms for biomedical applications.
Borden M, Attawia M, Laurencin CT. The sintered microsphere matrix for bone tissue engineering: in vitro osteoconductivity studies. *Journal of Biomedical Materials Research. 2002;61:421–42.
2.
Dash TK, Konkimalla VB. Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review. *Journal of Controlled Release. 2012;158*(1:15–33.
3.
Kojic M, Milosevic M, Simic V, Stojanovic D, Uskokovic P. A radial 1D Finite Element for Drug Release from Drug Loaded Nanofibers. *Journal of the Serbian Society for Computational Mechanics. 2017;11*(1:82–93.
4.
Kojic M, Milosevic M, Ziemys A. *Computational Models in Biomedical Engineering - Finite Element Models Based on Smeared Physical Fields: Theory, Solutions, and Software*. 2022.
5.
Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory’s experience. *Accounts of Chemical Research. 2000;33:94–10.
6.
Makadia HK, Siegel SJ. Poly Lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. *Polymers. 2011;3:1377–97.
7.
Milosevic M, Stojanovic D, Simic V, Milicevic B, Radisavljevic A, Uskokovic P, et al. A Computational Model for Drug Release from PLGA Implant. *Materials. 2018;11*(12:2416.
8.
Milosevic M, Stojanovic DB, Simic V, Grkovic M, Bjelovic MP, Uskokovic S, et al. Preparation and modeling of three‐layered PCL/PLGA/PCL fibrous scaffolds for prolonged drug release. 2020.
9.
Park TG, Alonso MJ, Langer R. Controlled release of proteins from poly (l‐lactic acid) coated polyisobutylcyanoacrylate microcapsules. *Journal of Applied Polymer Science. 1994;52:1797–807.
10.
Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. *Biomaterials. 1995;16:1123–30.
11.
Rai A, Senapati S, Saraf SK, Maiti P. Biodegradable poly(ε-caprolactone) as a controlled drug delivery vehicle of vancomycin for the treatment of MRSA infection. *Journal of Materials Chemistry B. 2016;4:5151–60.
12.
Ruiz-Esparza GU. Polymer nanoparticles enhanced in a cyclodextrin complex shell for potential site- and sequence-specific drug release. *Advanced Functional Materials. 2014;24:4753–61.
13.
Sackett CK, Narasimhan B. Mathematical modeling of polymer erosion: Consequences for drug delivery. *International Journal of Pharmaceutics. 2011;418:104–14.
14.
Singh NK. Nanostructure controlled anti-cancer drug delivery using poly(ε-caprolactone) based nanohybrids. *Journal of Materials Chemistry. 2012;22:17853–63.
15.
Siepmann J, Geopferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. *Advanced Drug Delivery Reviews. 2001;48:229–47.
16.
Zhu X, Braatz RD. A mechanistic model for drug release in PLGA biodegradable stent coatings coupled with polymer degradation and erosion. *Journal of Biomedical Materials Research Part A. 2015;103:2269–79.
17.
Zhang L, Gao Y, Zhu ZT, Fong H. Preparation, characterization, and encapsulation/release studies of a composite nanofiber mat electrospun from an emulsion containing poly (lactic-co-glycolic acid. *Polymer. 2008;49*(24:5294–9.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
